JAFRAL is proud to be sponsoring Bacteriophage Therapy Summit that will be held 25-27th of March 2019 in Boston, US.
JAFRAL is proud to be a GMP manufacturing partner of a consortium/project for first clinical trial on combined electrochemotherapy with gene therapy with Interleukin-12 (IL-12) to improve/enhance local and systemic response to skin tumor treatment.
On 20th September 2017, WHO launched report about antibacterial agents in clinical development – an analysis of the antibacterial clinical development pipeline, including tuberculosis. Report shows a
Because there have not been rigorous clinical trials of phages, they can be used only on patients for whom all other options have failed.
US regulators on Wednesday approved the first gene therapy against cancer - a treatment that uses a patient's own immune cells to fight leukemia - opening a new era in the fight against one of the